Skip to main content
OpenTrials

Clinical trial condition

Hepatitis

Explore clinical trials studying Hepatitis. Study availability and eligibility vary by location and protocol.

2,969 public trials 189 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis trial results

Completed

Tenofovir Disoproxil Fumarate (TDF) 300mg 3 Years RD Therapy Chinese Chronic Hepatitis B (CHN) CHB Multiple Nucleos(t)Ide Analogues (NAs) Failure Points Pts PH4 PMS Study

NCT02195518

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Guangzhou, Guangdong, China
  • GSK Investigational Site Guangzhou, Guangdong, China
  • GSK Investigational Site Changchun, Jilin, China
  • GSK Investigational Site Chengdu, Sichuan, China
View Trial Details
Completed

Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B

NCT01943799

Conditions
Blood-Borne Infections, Chronic HBV Infection, Communicable Diseases, +9 more
Locations
  • Dumont-UCLA Liver Transplant Center Los Angeles, California, United States
  • Huntington Medical Research Institutes Pasadena, California, United States
  • Kaiser Permanente Sacramento, California, United States
  • Kaiser Permanente San Diego, California, United States
View all 17 locations
View Trial Details
Completed

Quality of Life Measurement in Treatment Naïve Patients With Hepatitis C Virus (HCV) Genotype 1 (GT1) Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®)

NCT03002818

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus (HCV), +15 more
Locations
  • Kantonsspital St. Gallen Sankt Gallen, Canton of St. Gallen, Switzerland
  • Inselspital, Universitaetsklin Bern, Switzerland
  • Fondazione Epatocentro Ticino Lugano, Switzerland
  • Hopital Neuchatelois Neuchâtel, Switzerland
View Trial Details
Completed

Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B Subjects

NCT02431312

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • Research and Education, Inc. San Diego, California, United States
  • University of Miami Schiff Center for Liver Disease Miami, Florida, United States
  • Northwell Health Manhasset, New York, United States
  • Mount Sinai - PRIME New York, United States
View all 22 locations
View Trial Details
Completed

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C

NCT02803138

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • Soroka Medical Center /ID# 169357 Beersheba, Southern District, Israel
  • Rabin Medical Center /ID# 153696 Petakh Tikva, Tel Aviv, Israel
  • Rabin Medical Center /ID# 158648 Petakh Tikva, Tel Aviv, Israel
  • Tel Aviv Sourasky Medical Ctr /ID# 153693 Tel Aviv, Israel
View all 18 locations
View Trial Details

Related conditions